With the purchase of Olson Communications, the agency aims to serve clients eager for expertise from outside the healthcare industry.
Success today is predicated on recognizing that every patient is different, every disease is different, every drug, every breakthrough and every cure is different.
"Today's conversations between sales reps and their HCP customers often include talk about a drug's savings offer. And on the non-personal/digital front, many of pharma's biggest brands are putting cost savings front and center."
Craig Sullivan is tapped to take over as president upon Abbate's retirement at the end of the year.
Bayer Consumer consolidates agency business; Publicis offers $3.7 billion for Sapient; Boehringer Ingelheim signs option deal for fatal lung disease drug.
Standouts from the pharma, agency and media worlds aligned on the evening of October 2, as the industry saluted the winners of the 2014 MM&M Awards. Click on the slideshow below to see a gallery of pictures from the event
The next generations will engage with the digital world in a way that could effect real change in breast cancer.
MM&M senior editor, Larry Dobrow, discusses sales force enablement with Rich Daly, managing partner at RavineRock Partners and former president of US diabetes for AstraZeneca.
MM&M senior editor, Larry Dobrow, discusses innovation in diabetes with Guy Platt, business development executive of Boston Therapeutics.
MM&M senior editor Larry Dobrow discusses how to optimize the user experience on digital sales tools with Jose Andrade, VP, director of interactive technology and Emily Tower, VP of digital strategy and analytics for AbelsonTaylor.
Top 100 Agency Profiles
Click here to access the profiles
The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.